PROVECTUS BIOPHARMACEUTICALS I (PVCT) Stock Price, Quote, News and Overview
NYSEARCA:PVCT - NYSE Arca - US74373P1084
PVCT Quote, Performance and Key Statistics
PROVECTUS BIOPHARMACEUTICALS I
NYSEARCA:PVCT (10/13/2016, 8:13:33 PM)
0.05
-0.02 (-28.57%)
The current stock price of PVCT is 0.05 null. In the past month the price decreased by -50%. In the past year, price decreased by -90.91%.
About PVCT
Company Profile
Provectus Biopharmaceuticals specializes in developing oncology and dermatology therapies. The company's product portfolio consists of PV-10 Melanoma, PH-10 Psoriasis, PH-10 Atopic Dermatitis, PV-10 Breast Cancer, PV-10 Liver Metastasis and PV-10 Mechanism of Action which are in clinical trials. Provectus Biopharmaceuticals Inc., formerly known as Provectus Pharmaceuticals, Inc., is based in Knoxville, Tennessee.
Company Info
PROVECTUS BIOPHARMACEUTICALS I
7327 OAK RIDGE HIGHWAY SUITE A
KNOXVILLE TN 37931
CEO: Alfred E. Smith IV
Phone: 866-594-5999
PROVECTUS BIOPHARMACEUTICALS I / PVCT FAQ
What is the stock price of PROVECTUS BIOPHARMACEUTICALS I today?
The current stock price of PVCT is 0.05 null. The price decreased by -28.57% in the last trading session.
What is the ticker symbol for PROVECTUS BIOPHARMACEUTICALS I stock?
The exchange symbol of PROVECTUS BIOPHARMACEUTICALS I is PVCT and it is listed on the NYSE Arca exchange.
On which exchange is PVCT stock listed?
PVCT stock is listed on the NYSE Arca exchange.
What is PROVECTUS BIOPHARMACEUTICALS I worth?
PROVECTUS BIOPHARMACEUTICALS I (PVCT) has a market capitalization of 18.52M null. This makes PVCT a Nano Cap stock.
Should I buy PROVECTUS BIOPHARMACEUTICALS I (PVCT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PVCT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PVCT, evaluating the profitability, health, valuation and growth aspects
- PROVECTUS BIOPHARMACEUTICALS I (PVCT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PROVECTUS BIOPHARMACEUTICALS I (PVCT) Sales and EPS estimates to see what analysts future expectations are.
- PROVECTUS BIOPHARMACEUTICALS I (PVCT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PROVECTUS BIOPHARMACEUTICALS I (PVCT) Insider and Institutional Ownership to learn about the owners and their transactions.
- PROVECTUS BIOPHARMACEUTICALS I (PVCT) Stock Chart to make your own analysis
- PROVECTUS BIOPHARMACEUTICALS I (PVCT) Latest news and press-releases to stay up to date.
Does PROVECTUS BIOPHARMACEUTICALS I (PVCT) stock pay dividends?
PVCT does not pay a dividend.
When does PROVECTUS BIOPHARMACEUTICALS I (PVCT) report earnings?
PROVECTUS BIOPHARMACEUTICALS I (PVCT) will report earnings on 2022-04-12.
What is the Price/Earnings (PE) ratio of PROVECTUS BIOPHARMACEUTICALS I (PVCT)?
PROVECTUS BIOPHARMACEUTICALS I (PVCT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).
What is the Short Interest ratio of PROVECTUS BIOPHARMACEUTICALS I (PVCT) stock?
The outstanding short interest for PROVECTUS BIOPHARMACEUTICALS I (PVCT) is 0% of its float. Check the ownership tab for more information on the PVCT short interest.
PVCT Technical Analysis
PVCT Financial Highlights
Over the last trailing twelve months PVCT reported a non-GAAP Earnings per Share(EPS) of -0.05.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 100.15% | ||
| ROA | -257.04% | ||
| ROE | -478.66% | ||
| Debt/Equity | 0 |